
Αξιολόγηση του κινδύνου ανάπτυξης ηπατοκυτταρικού καρκίνου σε ασθενείς με χρόνια ηπατίτιδα C
Lu M, Salgia R, Li J, et al. Dynamic risk assessment for hepatocellular carcinoma in patients with chronic hepatitis C. J Viral Hepat 2023;30:746–755. DOI:

Lu M, Salgia R, Li J, et al. Dynamic risk assessment for hepatocellular carcinoma in patients with chronic hepatitis C. J Viral Hepat 2023;30:746–755. DOI:

Huang D, Tran A, Yeh ML, Yasuda S, Tsai PC, Pei-Chien H, et al. Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis

Chun HS, Papatheodoridis GV, Lee M, Lee HA, Kim YH, Kim SH, Oh YS, Park SJ, Kim J, Lee HA, Kim HY, Kim TH, Yoon

Thompson A, Jackson K, Bonanzinga S, Hall S, Hume S, Burns G, Sundararajan V, et al. Hepatology Communications 7(8), August 2023. DOI: 10.1097/HC9.0000000000000188 Δείτε ΕΔΩ

Jae Seung Lee, Chan-Young Jung, Jung Il Lee, Sang Hoon Ahn, Beom Seok Kim, Seung Up Kim. Comparison of decline in renal function between patients